title: Telomere dysfunction triggers extensive DNA fragmentation and evolution of complex chromosome abnormalities in human malignant tumors.
abstract: Although mechanisms for chromosomal instability in tumors have been described in animal and in vitro models, little is known about these processes in man. To explore cytogenetic evolution in human tumors, chromosomal breakpoint profiles were constructed for 102 pancreatic carcinomas and 140 osteosarcomas, two tumor types characterized by extensive genomic instability. Cases with few chromosomal alterations showed a preferential clustering of breakpoints to the terminal bands, whereas tumors with many changes showed primarily interstitial and centromeric breakpoints. The terminal breakpoint frequency was negatively correlated to telomeric TTAGGG repeat length, and fluorescence in situ hybridization with telomeric TTAGGG probes consistently indicated shortened telomeres and >10% of chromosome ends lacking telomeric signals. Because telomeric dysfunction may lead to formation of unstable ring and dicentric chromosomes, mitotic figures were also evaluated. Anaphase bridges were found in all cases, and fluorescence in situ hybridization demonstrated extensive structural rearrangements of chromosomes, with terminal transferase detection showing fragmented DNA in 5-20% of interphase cells. Less than 2% of cells showed evidence of necrosis or apoptosis, and telomerase was expressed in the majority of cases. Telomeric dysfunction may thus trigger chromosomal fragmentation through persistent bridge-breakage events in pancreatic carcinomas and osteosarcomas, leading to a continuous reorganization of the tumor genome. Telomerase expression is not sufficient for completely stabilizing the chromosome complement but may be crucial for preventing complete genomic deterioration and maintaining cellular survival.
authors.affiliation: Department of Clinical Genetics, University Hospital, SE-221 85 Lund, Sweden. david.gisselsson@klingen.lu.se
authors.forename: D
authors.initials: D
authors.lastname: Gisselsson
authors.forename: T
authors.initials: T
authors.lastname: Jonson
authors.forename: A
authors.initials: A
authors.lastname: Petersén
authors.forename: B
authors.initials: B
authors.lastname: Strömbeck
authors.forename: P
authors.initials: P
authors.lastname: Dal Cin
authors.forename: M
authors.initials: M
authors.lastname: Höglund
authors.forename: F
authors.initials: F
authors.lastname: Mitelman
authors.forename: F
authors.initials: F
authors.lastname: Mertens
authors.forename: N
authors.initials: N
authors.lastname: Mandahl
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D002470:Cell Survival; D002869:Chromosome Aberrations; D053938:DNA Fragmentation; D005260:Female; D006801:Humans; D007399:Interphase; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000235:genetics*; D012091:Repetitive Sequences, Nucleic Acid; D019098:Telomerase / Q000378:metabolism; D016615:Telomere
chemical_list: D019098:Telomerase